The commercial approval in June 2006 of the first HPV vaccine, Gardasil (recombinant HPV subtypes 6/11/16/18), marketed by Whitehouse Station, New Jersey–based Merck, has enabled Ian Frazer to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback